Retrieve available abstracts of 54 articles: HTML format
Single Articles
May 2025
SHIBATA H, Fujiyoshi T, Kawata N, Obayashi T, et al Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection
in Patients Taking Antithrombotic Agents.
J Gastroenterol Hepatol. 2025 May 27. doi: 10.1111/jgh.17027. PubMedAbstract available
JING W, Yan H, Xia S, Wang Z, et al A Rare Case of Refractory Duodenal Ulcer With Progressive Aggravation Despite
Conventional Treatment.
J Gastroenterol Hepatol. 2025 May 16. doi: 10.1111/jgh.17007. PubMedAbstract available
April 2025
BAIK M, Jeon J, Yoo J, Kim J, et al Effect of Potassium-Competitive Acid Blockers on Upper Gastrointestinal Bleeding
in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary
Intervention: A Nationwide Cohort Study.
J Gastroenterol Hepatol. 2025 Apr 27. doi: 10.1111/jgh.16989. PubMedAbstract available
Correction to "Endoscopic Versus Medical Management of Peptic Ulcers With
Adherent Clots: Overcoming Hesitation Through Education".
J Gastroenterol Hepatol. 2025 Apr 21. doi: 10.1111/jgh.16983. PubMed
SI YT, Xiong XS, Zhang SK, Lai JX, et al Detection of Helicobacter pylori Infection and Antibiotic Resistance via String
Test Coupled With qPCR Method: A Comparative Methodological Study.
J Gastroenterol Hepatol. 2025 Apr 2. doi: 10.1111/jgh.16962. PubMedAbstract available
March 2025
WU J, Liao Y Balancing Benefits and Risks: The Role of Tranexamic Acid in Upper
Gastrointestinal Bleeding.
J Gastroenterol Hepatol. 2025 Mar 15. doi: 10.1111/jgh.16941. PubMed
February 2025
JEARTH V Management of Helicobacter pylori Infection: Do We Completely See Eye to Eye?
J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1111/jgh.16904. PubMed
December 2024
OTANI K, Hang DV, Pittayanon R, Liu H, et al Asia-Pacific Survey on the Management of Helicobacter pylori Infection.
J Gastroenterol Hepatol. 2024 Dec 26. doi: 10.1111/jgh.16862. PubMedAbstract available
KAN SW, Tan YP, Tay MZ, Chi MJ, et al Tranexamic Acid With Acid Suppression Versus Acid Suppression Alone as Therapy
for Upper Gastrointestinal Bleeding: A Meta-Analysis of Randomized Controlled
Trials.
J Gastroenterol Hepatol. 2024 Dec 4. doi: 10.1111/jgh.16842. PubMedAbstract available
FUKASE H, Futagami S, Yamamoto T, Masaoka T, et al Investigation of the effects of a new transdermal formulation of systemic
diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A
comparative study with oral diclofenac.
J Gastroenterol Hepatol. 2024;39:2504-2510. PubMedAbstract available
November 2024
LIN A, Lin Z, Liu Y, Chen S, et al Ten-day versus 14-day vonoprazan-amoxicillin high-dose dual therapy for
Helicobacter pylori eradication in China: A multicenter, open-label, randomized
study.
J Gastroenterol Hepatol. 2024 Nov 24. doi: 10.1111/jgh.16761. PubMedAbstract available
KAZAKOS E, Kountouras J Helicobacter pylori Infection and Cholelithiasis.
J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16820. PubMed
JUNG YS, Jung BW, Park CH Comparative efficacy of Helicobacter pylori eradication therapy between
tegoprazan-based concomitant and bismuth quadruple therapies: A real-world
evidence.
J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16798. PubMedAbstract available
October 2024
TAN JT, Cheung CL, Cheung KS Relationship between Helicobacter pylori infection, osteoporosis, and fracture.
J Gastroenterol Hepatol. 2024;39:2006-2017. PubMedAbstract available
September 2024
HO CT, Tan EH, Lee PC, Su CW, et al Reply to "Association between proton-pump inhibitor use and recurrence of
hepatocellular carcinoma after hepatectomy: concerns to be addressed".
J Gastroenterol Hepatol. 2024 Sep 19. doi: 10.1111/jgh.16754. PubMed
TANG WZ, Li JZ, Liu TH Evaluating vonoprazan bismuth-containing triple therapy versus quadruple therapy
for Helicobacter pylori.
J Gastroenterol Hepatol. 2024 Sep 18. doi: 10.1111/jgh.16753. PubMed
August 2024
JUNG BW, Park CH, Jung YS Efficacy and safety of tegoprazan- and rabeprazole-based concomitant therapies
for Helicobacter pylori infection: Real-world evidence.
J Gastroenterol Hepatol. 2024 Aug 26. doi: 10.1111/jgh.16719. PubMedAbstract available
PAVONI M, Fiorini G, Zullo A, Saracino IM, et al Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy
empirically prescribed in Helicobacter pylori-infected naive patients: a
retrospective study.
J Gastroenterol Hepatol. 2024 Aug 26. doi: 10.1111/jgh.16731. PubMedAbstract available
ISHIBASHI F, Suzuki S, Kobayashi K, Tanaka R, et al Cost-effective endoscopic screening for gastric cancer in a cohort with low
Helicobacter pylori prevalence.
J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16715. PubMedAbstract available
LIU J, Yin M, Lv C, Wang W, et al Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline
impedance predict proton pump inhibitor response in patients with reflux
hypersensitivity.
J Gastroenterol Hepatol. 2024 Aug 8. doi: 10.1111/jgh.16718. PubMedAbstract available
HAYASAKA J, Hoteya S, Takazawa Y, Kikuchi D, et al Antacids and reflux esophagitis as a risk factor for gastric neoplasm of
fundic-gland type: A retrospective, matched case-control study.
J Gastroenterol Hepatol. 2024;39:1580-1585. PubMedAbstract available
July 2024
BIAN J, Sang X Association between proton-pump inhibitor use and recurrence of hepatocellular
carcinoma after hepatectomy: Concerns to be addressed.
J Gastroenterol Hepatol. 2024 Jul 25. doi: 10.1111/jgh.16694. PubMed
LIANG JW, Xiong S, Jia YG, Xiao D, et al Comparison of vonoprazan bismuth-containing triple therapy with quadruple therapy
in Helicobacter pylori-infected treatment-naive patients: a prospective
multicenter randomized controlled trial.
J Gastroenterol Hepatol. 2024 Jul 16. doi: 10.1111/jgh.16679. PubMedAbstract available
June 2024
ALLO G, Nierhoff D, Kasper P Endoscopic versus medical management of peptic ulcers with adherent clots:
Overcoming hesitation through education.
J Gastroenterol Hepatol. 2024 Jun 18. doi: 10.1111/jgh.16665. PubMed
HO CT, Fu CC, Tan EC, Kao WY, et al The association between proton-pump inhibitor use and recurrence of
hepatocellular carcinoma after hepatectomy.
J Gastroenterol Hepatol. 2024 Jun 12. doi: 10.1111/jgh.16640. PubMedAbstract available
WEI MH, Chen CC, Lee HC, Lee YC, et al Prevalence of functional esophageal disorders and associated clinical
characteristics in patients with proton-pump-inhibitor-unresponsive reflux
symptoms.
J Gastroenterol Hepatol. 2024 Jun 11. doi: 10.1111/jgh.16654. PubMedAbstract available
May 2024
TASSONE D, Kazi S, Lee T, Gilmore R, et al Systematic review and meta-analysis of endoscopic versus medical management of
peptic ulcers with adherent clots.
J Gastroenterol Hepatol. 2024 May 31. doi: 10.1111/jgh.16611. PubMedAbstract available
SCHUBERT JP, Tay A, Lee KHC, Leong LEX, et al Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance,
phylogenetic patterns, and virulence factors.
J Gastroenterol Hepatol. 2024 May 29. doi: 10.1111/jgh.16636. PubMedAbstract available
SONODA M, Matsumura T, Dao HV, Shiko Y, et al A prediction model of abnormal acid reflux in gastroesophageal reflux disease.
J Gastroenterol Hepatol. 2024 May 15. doi: 10.1111/jgh.16602. PubMedAbstract available
KOUNTOURAS J, Zavos C, Vardaka E, Kyrailidi F, et al Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic
fatty liver disease pathophysiology.
J Gastroenterol Hepatol. 2024 May 9. doi: 10.1111/jgh.16621. PubMed
LOOSEN SH, Killer A, Luedde T, Roderburg C, et al Helicobacter pylori infection associated with an increased incidence of
cholelithiasis: A retrospective real-world cohort study of 50 832 patients.
J Gastroenterol Hepatol. 2024 May 7. doi: 10.1111/jgh.16597. PubMedAbstract available
CHEUNG KS, Yan VKC, Ye X, Hung IFN, et al Proton pump inhibitors associated with severe COVID-19 among two-dose but not
three-dose vaccine recipients.
J Gastroenterol Hepatol. 2024 May 5. doi: 10.1111/jgh.16601. PubMedAbstract available
ZHAO X, Ciren Y, Wu D Gastrointestinal: A rare intra-abdominal hydatid cyst manifesting as an acute
massive upper gastrointestinal bleeding.
J Gastroenterol Hepatol. 2024 May 2. doi: 10.1111/jgh.16579. PubMed
February 2024
SOGABE M, Okahisa T, Kagawa M, Sei M, et al Association of metabolic dysfunction-associated steatotic liver disease with
erosive esophagitis development: a longitudinal observational study.
J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530. PubMedAbstract available
YAMAOKA Y Revolution of Helicobacter pylori treatment.
J Gastroenterol Hepatol. 2024 Feb 27. doi: 10.1111/jgh.16526. PubMedAbstract available
KIM NH, Chang Y, Ryu S, Sohn CI, et al Impact of metabolic unhealthiness and its changes on the risk of erosive
esophagitis: a cohort study.
J Gastroenterol Hepatol. 2024 Feb 21. doi: 10.1111/jgh.16519. PubMedAbstract available
SIMADIBRATA DM, Lesmana E, Fass R Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive
esophagitis: A systematic review with meta-analysis of randomized controlled
trials.
J Gastroenterol Hepatol. 2024 Feb 14. doi: 10.1111/jgh.16486. PubMedAbstract available
AYAR MS, Baydin A, Ustaoglu M, Caliskan F, et al Inferior vena cava collapsibility index and stroke volume as predictors of blood
transfusion in upper gastrointestinal bleeding in the emergency department.
J Gastroenterol Hepatol. 2024 Feb 9. doi: 10.1111/jgh.16500. PubMedAbstract available
January 2024
SIMADIBRATA DM, Lesmana E, Fass R A systematic review and meta-analysis of the efficacy of vonoprazan for proton
pump inhibitor-resistant gastroesophageal reflux disease.
J Gastroenterol Hepatol. 2024 Jan 23. doi: 10.1111/jgh.16475. PubMedAbstract available
ZHUANG Q, Liao A, He Q, Liu C, et al The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase
III, randomized, double-blind, multicenter study.
J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1111/jgh.16471. PubMedAbstract available
MUFTAH M, Hartnett DA, Flanagan R, Redd WD, et al Allergic phenotype identified on allergen testing is associated with proton pump
inhibitor nonresponse in eosinophilic esophagitis.
J Gastroenterol Hepatol. 2024 Jan 7. doi: 10.1111/jgh.16469. PubMedAbstract available
November 2023
SUN Y, Zhang A, Zuo M, Chen J, et al A pharmacovigilance study of association between proton-pump inhibitors and
rhabdomyolysis event based on FAERS database.
J Gastroenterol Hepatol. 2023 Nov 14. doi: 10.1111/jgh.16411. PubMedAbstract available
BAILEY ME, Borges LF, Goldberg HJ, Hathorn KE, et al Abnormal bolus reflux on impedance-pH testing independently predicts 3-year
pulmonary outcome and mortality in pulmonary fibrosis.
J Gastroenterol Hepatol. 2023;38:1998-2005. PubMedAbstract available
NABI Z, Ramchandani M, Basha J, Inavolu P, et al Per-oral endoscopic myotomy in cases with prior Heller's myotomy: Outcomes at a
median follow-up of 5 years.
J Gastroenterol Hepatol. 2023;38:2035-2039. PubMedAbstract available
October 2023
SHIMAMURA Y, Inoue H, Tanabe M, Ushikubo K, et al Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux
disease: An international bi-institutional study.
J Gastroenterol Hepatol. 2023 Oct 3. doi: 10.1111/jgh.16370. PubMedAbstract available
September 2023
ZENG SY, Wang J, Liu J, Lin MJ, et al Efficacy and safety of a 14-day modified concomitant therapy for refractory
Helicobacter pylori infection: a pilot study.
J Gastroenterol Hepatol. 2023 Sep 13. doi: 10.1111/jgh.16348. PubMedAbstract available
August 2023
YU Y, Liao Z, Jiang X, Pan J, et al The use of magnet-controlled capsule endoscopy as the initial diagnostic tool in
patients with acute upper gastrointestinal bleeding.
J Gastroenterol Hepatol. 2023 Aug 3. doi: 10.1111/jgh.16310. PubMedAbstract available
OHKI D, Tsuji Y, Kuroda R, Ushiku T, et al Gastrointestinal: A case of significant esophageal ulceration due to oral iron
pill therapy.
J Gastroenterol Hepatol. 2023;38:1241. PubMed
July 2023
YOU N, Chen Y, Yan X, Gu B, et al Persistent Helicobacter pylori infection leads to elevated fasting plasma glucose
level: A retrospective cohort study based on a nondiabetes Chinese population.
J Gastroenterol Hepatol. 2023 Jul 4. doi: 10.1111/jgh.16275. PubMedAbstract available
June 2023
EL HAGE CHEHADE N, Fu Y, Ghoneim S, Shah S, et al Association between obstructive sleep apnea and gastroesophageal reflux disease:
A systematic review and meta-analysis.
J Gastroenterol Hepatol. 2023 Jun 10. doi: 10.1111/jgh.16245. PubMedAbstract available
April 2023
GULIYARA MA, Ermerak G, Levy M, Koo JH, et al Frailty predicts mortality in patients with Upper Gastrointestinal bleed: A
prospective cohort study.
J Gastroenterol Hepatol. 2023 Apr 1. doi: 10.1111/jgh.16188. PubMedAbstract available
March 2023
CHANG A, Rugivarodum M, Pungpipattrakul N, Akarapatima K, et al Role of Oral Iron Supplementation for Anemia Secondary to Acute Nonvariceal Upper
Gastrointestinal Bleeding: A Randomized Controlled Trial.
J Gastroenterol Hepatol. 2023 Mar 30. doi: 10.1111/jgh.16185. PubMedAbstract available
SARUTA Y, Watanabe K, Tsuji T, Takahashi Y, et al Vonoprazan poses no additional risk of developing Clostridioides difficile
infection compared to proton pump inhibitors.
J Gastroenterol Hepatol. 2023 Mar 7. doi: 10.1111/jgh.16169. PubMedAbstract available
MATSUURA N, Kato M, Irino T, Hirata K, et al Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric
phenotype.
J Gastroenterol Hepatol. 2023;38:347. PubMed